Extracellular Vesicles Released by ALL Patients Contain HNE-adducted Proteins: Implications of Collateral Damage

Overview

Journal Free Radic Biol Med

Specialties Biochemistry
Biology
General Medicine

Date 2024 Dec 6

PMID 39643137

Authors

Jenni Ho

Suriyan Sukati

Tamara Taylor

Sherry Carter

Brittany Fuller

Amy Marmo

Caryn Sorge

John DOrazio

D Allan Butterfield

Subbarao Bondada

Heidi Weiss

Daret K St Clair

Luksana Chaiswing

Affiliations

Soon will be listed here.

Abstract

Off-target neuronal injury is a serious side-effect observed in cancer survivors. It has previously been shown that pediatric acute lymphoblastic leukemia (ALL) survivors have a decline in neurocognition compared to healthy age-matched counterparts. Elevated oxidative stress has been documented to be a mediator in off-target tissue damage in cancer survivors. Early detection of oxidative stress markers may provide an opportunity to prevent off-target tissue damage. Extracellular vesicles (EVs) have surfaced as a potential diagnostic tool due to molecular cargo they contain. We investigated the potential for EVs to be a sensitive indicator of oxidative stress and off-target tissue damage by isolating EVs from pediatric ALL patients throughout their first 2 months of treatment. EVs were measured throughout the collection points for: 1) number of EV particles generated using nanoparticle tracking analysis (NTA); 2) markers of neurons (NeuN), astrocyte activation (GFAP), neuronal stability (BDNF), 3) markers of pre-B cell ALL (CD19 and CD22); and) 4-hydroxy-2-nonenal (HNE) adducted proteins. HNE protein adductions were measured in the patient sera and CSF. Pro-inflammatory cytokine levels were also measured in patient sera because of their contribution to oxidative stress and neuronal injury. Our results: 1) demonstrate EVs are a sensitive indicator of oxidative damage; 2) suggest EVs as a marker of a decline in neuronal stability; and 3) show the presence of leukemia has a greater contribution to pro-inflammatory cytokine production in the patient's serum than the cancer treatment. Specifically, we observed a significant decrease in cytokine levels (e.g., TNF-α, IL-1β, IL-6, and IL-8) following the initiation of treatment, highlighting the influence of leukemia burden on systemic inflammation. The results support the utilization of EVs as a sensitive marker of oxidative stress and off-target tissue damage.

References

Angiolillo A, Schore R, Kairalla J, Devidas M, Rabin K, Zweidler-McKay P . Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932. J Clin Oncol. 2021; 39(13):1437-1447. PMC: 8274746. DOI: 10.1200/JCO.20.00494. View

Alexander M, Hu R, Runtsch M, Kagele D, Mosbruger T, Tolmachova T . Exosome-delivered microRNAs modulate the inflammatory response to endotoxin. Nat Commun. 2015; 6:7321. PMC: 4557301. DOI: 10.1038/ncomms8321. View

van Niel G, DAngelo G, Raposo G . Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018; 19(4):213-228. DOI: 10.1038/nrm.2017.125. View

Tsao N, Hsu H, Wu C, Liu C, Lei H . Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J Med Microbiol. 2001; 50(9):812-821. DOI: 10.1099/0022-1317-50-9-812. View

Butterfield D, Halliwell B . Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019; 20(3):148-160. PMC: 9382875. DOI: 10.1038/s41583-019-0132-6. View

Sukati S, Ho J, Chaiswing L, Sompol P, Pandit H, Wei W . Extracellular vesicles released after cranial radiation: An insight into an early mechanism of brain injury. Brain Res. 2022; 1782:147840. PMC: 8918058. DOI: 10.1016/j.brainres.2022.147840. View

Welsh J, van der Pol E, Arkesteijn G, Bremer M, Brisson A, Coumans F . MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments. J Extracell Vesicles. 2020; 9(1):1713526. PMC: 7034442. DOI: 10.1080/20013078.2020.1713526. View

Phillips D, Woollard K, Griffiths H . The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br J Pharmacol. 2003; 138(3):501-11. PMC: 1573681. DOI: 10.1038/sj.bjp.0705054. View

Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G . Corrigendum: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2016; 22(12):1502. DOI: 10.1038/nm1216-1502b. View

10.

Galea I . The blood-brain barrier in systemic infection and inflammation. Cell Mol Immunol. 2021; 18(11):2489-2501. PMC: 8481764. DOI: 10.1038/s41423-021-00757-x. View

11.

Meyers C, Albitar M, Estey E . Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2005; 104(4):788-93. DOI: 10.1002/cncr.21234. View

12.

Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

13.

Middeldorp J, Hol E . GFAP in health and disease. Prog Neurobiol. 2011; 93(3):421-43. DOI: 10.1016/j.pneurobio.2011.01.005. View

14.

Madeo M, Colbert P, Vermeer D, Lucido C, Cain J, Vichaya E . Cancer exosomes induce tumor innervation. Nat Commun. 2018; 9(1):4284. PMC: 6191452. DOI: 10.1038/s41467-018-06640-0. View

15.

Campbell L, Scaduto M, Sharp W, Dufton L, Van Slyke D, Whitlock J . A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer. 2006; 49(1):65-73. DOI: 10.1002/pbc.20860. View

16.

Daniels B, Holman D, Cruz-Orengo L, Jujjavarapu H, Durrant D, Klein R . Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. mBio. 2014; 5(5):e01476-14. PMC: 4173776. DOI: 10.1128/mBio.01476-14. View

17.

Zhang J, Sadowska G, Chen X, Park S, Kim J, Bodge C . Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus. FASEB J. 2015; 29(5):1739-53. PMC: 4771067. DOI: 10.1096/fj.14-258822. View

18.

Siegel D, Henley S, Li J, Pollack L, Van Dyne E, White A . Rates and Trends of Pediatric Acute Lymphoblastic Leukemia - United States, 2001-2014. MMWR Morb Mortal Wkly Rep. 2017; 66(36):950-954. PMC: 5657918. DOI: 10.15585/mmwr.mm6636a3. View

19.

Cheung Y, Sabin N, Reddick W, Bhojwani D, Liu W, Brinkman T . Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis. Lancet Haematol. 2016; 3(10):e456-e466. PMC: 5417340. DOI: 10.1016/S2352-3026(16)30110-7. View

20.

Shah R, Patel T, Freedman J . Circulating Extracellular Vesicles in Human Disease. N Engl J Med. 2018; 379(22):2180-2181. DOI: 10.1056/NEJMc1813170. View